Inflammatory cytokines (TNF-α, IL-1, IL-6) at tumor sites create a pro-autoimmune milieu where the immune system generates AAb against tumor-associated targets, potentially increasing autoimmune risk (30). Here, IL6 is linked to neoplasm.